Ticker Details
Relay Therapeutics, Inc.
IPO Date:	July 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.28B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.66 | 3.79%
Avg Daily Range (30 D):	$0.59 | 3.67%
Avg Daily Range (90 D):	$0.52 | 3.88%

Institutional Daily Volume
Avg Daily Volume:	1.19M
Avg Daily Volume (30 D):	3.5M
Avg Daily Volume (90 D):	3.22M

Trade Size
Avg Trade Size (Sh.):	93
Avg Trade Size (Sh.) (30 D):	94
Avg Trade Size (Sh.) (90 D):	95

Institutional Trades
Total Institutional Trades:	3,012
Avg Institutional Trade:	$2.4M
Avg Institutional Trade (30 D):	$4.13M
Avg Institutional Trade (90 D):	$3.43M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.12M
Avg Closing Trade (30 D):	$13.24M
Avg Closing Trade (90 D):	$8.18M
Avg Closing Volume:	225.03K

News

May 22, 2026 @ 9:30 PM Is Relay Therapeutics a Buy After Promising Trial ... Source: James Halley

May 21, 2026 @ 12:21 AM Relay Therapeutics Announces Pricing of Public Off... Source: Not Specified

May 20, 2026 @ 11:01 PM Why Relay Therapeutics Stock Popped on Wednesday Source: Eric Volkman

May 19, 2026 @ 10:00 AM Relay Therapeutics Announces Initial Clinical Data... Source: Na

Apr 27, 2026 @ 10:00 AM Relay Therapeutics Announces Clinical Data for Zov... Source: Relay Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.56	$-.41	$-.31
Diluted EPS	$-1.56	$-.41	$-.31
Revenue	$10.68M	$3M	$7M
Gross Profit
Net Income / Loss	$-272.71M	$-73.29M	$-54.89M
Operating Income / Loss	$-296.46M	$-78.59M	$-60.63M
Cost of Revenue
Net Cash Flow	$79.52M	$120.57M	$-8.47M
PE Ratio